Immune-Onc Therapeutics Company
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
Estimated Revenue:
$1M to $10M
Funding Status:
Early Stage Venture
Industry:
PharmTech
Technology:
Cancer
Founded Date:
2016
Headquarters:
Palo Alto, California, United States
Employee Number:
11-50